Structure and mechanism of action and inhibition of steroid dehydrogenase enzymes involved in hypertension

Endocrine Research

Volumn 24, Issue 3-4, 1998, Pages 521-529

  Duax, William L ^a   Ghosh, Debashis ^a,b  

^a HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA(OR 20BETA) HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; DIHYDROPTERIDINE REDUCTASE; ENZYME INHIBITOR; GLYCYRRHIZIC ACID; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; STEROID REDUCTASE; TYROSINE;

AMINO ACID SEQUENCE; CATALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME CONFORMATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; HYDROGEN BOND; HYPERTENSION; KIDNEY; NONHUMAN; PRIORITY JOURNAL;

EID: 0032415732     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.3109/07435809809032641     Document Type: Conference Paper

References (23)

1. Duax WL, Griffin JF. 1989. In: Testa B (ed) Advances in Drug Research. Academic Press, New York, pp. 115-138.
2. Evans RM. 1988 Science 240:889-895.
3. Jörnvall H, Persson B, Krook M, Atrian S, Gonzàlez-Duarte JJ, Ghosh D. 1995 Biochemistry 34:6003-6013.
4. Ghosh D, Wawrzak Z, Weeks CM, Duax WL, Erman M. 1994 Structure 2:629-640.
5. Varughese KI, Skinner MM, Whiteley JM, Matthews DA, Xuong NH. 1992 Proc Natl Acad Sci USA 89:6080-6084.
6. Duax WL, Griffin JF, Ghosh D. 1996. In: Hendrickson W & Blundell TL (eds.) Current Opinion in Structural Biology, Vol. 6.6. pp. 813-823.
7. Brünger AT. 1992 X-PLOR (Version 3.1) Manual. Yale University, New Haven, CT.
8. Jones TA. 1978 J Appl Crystallogr 11:268-272.
9. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. 1993 J Appl Crystallogr 26:283-291.
10. Ghosh D, Erman M, Wawrzak Z, Duax WL, Pangborn W. 1994 Structure 2:973-980.
11. Sweet F, Samant BR. 1980 Biochemistry 19:978-986.
12. Declercq JP, Germain G, Van Meerssche M. 1972 Crystal Struct Commun 1:13-15.
13. Girerd RJ, Rassaert CL, DiPasquale G, Kroc RL. 1958 Am J Physiol 194:241-245.
14. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramierz LC, Rauh W, Rosler A, Bradlow HL, New MI. 1979J Clin Endocrinol Metab 49:757.
15. Tsuganezawa H, Hayashi J, Fujii Y, Yamaji Y, Iyori M, Saruta T. 1995 Renal Physiol Biochem 19:66-72.
16. New MI, Oberfield SE, Carey R, Greig F, Ulick S, Levind LS. 1982. In: Mantero F, Biglieri E, Edwards CRW (eds) Serono Symposium No. 50, Endocrinology of Hypertension. Academic Press, London, pp. 85-101.
17. Mondor C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CRW. 1989 Endocrinology 125:1046-1053.
18. Ghosh D, Erman M, Pangborn W, Duax WL, Baker ME. 1992 J Steroid Biochem Mol Biol 42:849-853.
19. Ghosh D, Wawrzak Z, Pletnev V, Erman M, Duax WL, Pangborn W, Zhu D-W, Labrie F, Lin S-X 1995 Annals of NY Acad of Sci 761:341-343.
20. Soro A, Kingram MC, Tonolo G, Gloriose N, Fraser R. 1995 Hypertension 25:67-70.
21. Ghosh D, Pletnev VZ, Zhu DW, Wawrzak Z, Duax WL, Pangborn W, Labrie F, Lin S-X. 1995 Structure 3:503-513.
22. Tanaka N, Nonaka T, Yashimoto T, Tsura D, Mitsui Y. 1996 Biochemistry 35:7715-7730.
23. Tanaka N, Nonaka T, Nakanishi M, Deyashiki Y, Hara A, Mitsui Y. 1996 Structure 4:33-45.